Senior Driving Simulation Training for Subjective Cognitive Decline and Mild Cognitive Impairment
NCT05380284, Not applicable, Completed, Taipei Medical University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Senior Driving Simulation Training for Subjective Cognitive Decline and Mild Cognitive Impairment | ClinicalTrials.gov |
| NCT number | NCT05380284 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 90 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Taipei Medical University | ClinicalTrials.gov |
| Conditions | MCI, Subjective Cognitive Decline, Healthy Aging | ClinicalTrials.gov |
| Interventions | Senior Driving Simulation Training, Waiting list control | ClinicalTrials.gov |
| First posted | 2022-05-18 | ClinicalTrials.gov |
| Last updated | 2023-06-01 | ClinicalTrials.gov |
Registered outcomes 19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Mental set shifting, measured by Wisconsin Card Sorting Test | immediate post-test | Mental set shifting is one of the sub-categories of executive function | ClinicalTrials.gov |
| Primary | Change from Baseline Mental set shifting, measured by Wisconsin Card Sorting Test at 3 months | 3 months follow-up | Mental set shifting is one of the sub-categories of executive function | ClinicalTrials.gov |
| Primary | Working memory, measured by Digit span test | immediate post-test | Working memory is one of the sub-categories of executive function | ClinicalTrials.gov |
| Primary | Change from Baseline Working memory, measured by Digit span test at 3 months | 3 months follow-up | Working memory is one of the sub-categories of executive function | ClinicalTrials.gov |
| Primary | Inhibition, measured by the Stroop Color and Word Test | immediate post-test | Inhibition is one of the sub-categories of executive function | ClinicalTrials.gov |
| Primary | Change from Baseline Inhibition, measured by the Stroop Color and Word Test at 3 months | 3 months follow-up | Inhibition is one of the sub-categories of executive function | ClinicalTrials.gov |
| Secondary | Cognitive function measured by Montreal Cognitive Assessment | immediate post-test | Cognitive function measured by Montreal Cognitive Assessment | ClinicalTrials.gov |
| Secondary | Cognitive function measured by Cognitive Change Index(C-CCI) | immediate post-test | Cognitive function measured by Cognitive Change Index(C-CCI) | ClinicalTrials.gov |
| Secondary | Change from Baseline cognitive function by Montreal Cognitive Assessment at 3 months | 3 months follow-up | Change from Baseline cognitive function by Montreal Cognitive Assessment at 3 months | ClinicalTrials.gov |
| Secondary | Change from Baseline cognitive function by Cognitive Change Index(C-CCI)at 3 months | 3 months follow-up | Change from Baseline cognitive function by Cognitive Change Index(C-CCI)at 3 months | ClinicalTrials.gov |
| Secondary | EEG | immediate post-test | EEG power in delta, theta, alpha, and beta band | ClinicalTrials.gov |
| Secondary | Change from Baseline EEG at 3 months | 3 months follow-up | EEG power in delta, theta, alpha, and beta band | ClinicalTrials.gov |
| Secondary | Visual awareness measured by CANTAB | immediate post-test | Visual awareness measured by CANTAB | ClinicalTrials.gov |
| Secondary | Visual awareness measured by trail making test | immediate post-test | Visual awareness measured by trail making test | ClinicalTrials.gov |
| Secondary | Change from Baseline visual awareness by CANTAB at 3 months | 3 months follow-up | Visual awareness measured by CANTAB | ClinicalTrials.gov |
| Secondary | Change from Baseline visual awareness by trail making test at 3 months | 3 months follow-up | Change from Baseline visual awareness by trail making test at 3 months | ClinicalTrials.gov |
| Secondary | simulator sickness | immediate post-test | Simulator Sickness Questionnaire (SSQ). The 16-item SSQ will be used to assess participants' sickness levels. This is the 4-point Likert scale (0 - "None" to 3 - "Severe"), and the higher total score reflects more severe sickness. | ClinicalTrials.gov |
| Secondary | Usability | immediate post-test | The System Usability Scale (SUS) will be used to access the usability, this scale consists of 10 items, and the higher total score reflects better usability. | ClinicalTrials.gov |
| Secondary | Acceptance | immediate post-test | The Technology Acceptance for Older Adults Scale will be used to access the acceptance, this scale consists of 17 items, and the higher total score reflects better acceptance. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Primary outcome | ConductCognition |
| Digit Span Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)